| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8651005 | American Heart Journal | 2018 | 31 Pages |
Abstract
Demonstrating that prophylactic aspirin safely reduces the risk of CVD or cancer in the primary prevention setting, or that omega-3 FA supplementation prevents CVD, would be relevant to hundreds of millions of people worldwide who are currently not receiving such therapies. The results of ASCEND will be reported in 2018.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Louise MBBS, FRCP, Marion MRCP, MD, William PhD, Richard DM, FRCP, Theingi MRCP, Fang PhD, MBBS, Georgina MSc, Rory FRCP, FRS, Jane FRCP, FFPH, The ASCEND Study Collaborative Group The ASCEND Study Collaborative Group,